Page 41 - Cascade_Biocatalysis_Integrating_Stereoselective_and_Environmentally_Friendly_Reactions
P. 41

1.7 Conclusions and Outlook  17

               environments. However, this situation has changed with the development of
               directed evolution. In the last 10 years, a plethora of ideas for the construction of
               ligninolytic mutant libraries in S. cerevisiae has arisen to improve secretion, activity,
               and thermostability to broaden pH activity profiles and even to induce activity in
               blood or in organic co-solvents. And this is just the beginning. However, many
               challenges remain despite the great potential of these evolutionary platforms.
               We will have to deal with serious bottlenecks, such as the poor production of
               the mutants in different heterologous hosts (practical alternatives may exploit
               tandem expression systems with S. cerevisiae as a host for directed evolution and
               P. pastoris or Aspergillus niger for overexpression of the evolved variants [84]); the
               delicate balance between activity and stability when introducing beneficial (but
               destabilizing) mutations; and the difficulty of maintaining the redox potential
               of mutants after several rounds of evolution. In this context, the use of neutral
               genetic drift for the creation of polymorphic mutant libraries will open new
               adaptive pathways to enhance the stability or even the catalytic promiscuity of these
               oxidoreductases. Finally, the combination of directed evolution with both hybrid
               and rational approaches, including computational studies, will permit to convert
               this versatile array of high-redox potential oxidoreductases into real biotechnological
               products.



               Acknowledgments

               This chapter is based on research funded by projects: FP7-3D-Nanobiodevices,
               NMP4-SL-2009-229255; FP7-KBBE-2010-4-26537, Peroxicats; FP7-KBBE-2013-7-
               613549, Indox; COST Actions CM0701 CM0701-Cascat and CM1303-Sysbiocat;
               and a National Project BIO2010-19697-Evofacel).


               Abbreviations

               AAD         aryl-alcohol dehydrogenase
               AAO         aryl-alcohol oxidase
                             ′
               ABTS        2,2 -azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)
               CDH         cellobiose dehydrogenase
               CIP         Coprinopsis cinerea peroxidase
               CLERY       combinatorial libraries enhanced by recombination in yeast
               DMP         2,6-dimethoxyphenol
               EDTA        ethylenediamine-tetra-acetic acid
               GLX         glyoxal oxidase
               HRP         horseradish peroxidase
               HRPLs       high-redox potential laccases
               HTS         high-throughput screening
               I           Concentration of an inhibitory substance at which the enzyme
               50
                           retains 50% of its initial activity
   36   37   38   39   40   41   42   43   44   45   46